In a recent development, the Supreme Court of India has issued a stern warning to Patanjali Ayurved, the company co-founded by yoga guru Ramdev, cautioning against the propagation of “false” and “misleading” claims in its advertisements regarding the curative properties of its medicines.
The warning comes in response to a plea filed by the Indian Medical Association (IMA), expressing apprehensions about Patanjali Ayurved’s advertising practices. The Supreme Court, comprising Justices Ahsanuddin Amanullah and Prashant Kumar Mishra, took a firm stance, emphasizing the gravity of the issue during the hearing.
During the proceedings, the bench directed Patanjali Ayurved to cease all “false and misleading” advertisements immediately. The court warned that any violation of this directive would be taken seriously. Furthermore, the court is considering imposing substantial fines, up to Rs. 1 crore, for each product associated with a false curative claim.
This legal warning follows a notice issued by the Supreme Court on August 23, 2022, to the Union Health Ministry, Ministry of Ayush, and Patanjali Ayurved Ltd. The IMA had raised concerns about what it perceived as a smear campaign by Ramdev against the vaccination drive and modern medicines.
During the hearing, the Supreme Court urged Patanjali Ayurved to refrain from disseminating misleading information and advertisements, particularly those that undermine modern systems of medicine. The court indicated a potential financial penalty for each product associated with deceptive health claims.
In response to the legal warning, Ramdev addressed the media, alleging a concerted effort by a “gang of doctors” to propagate against yoga, Ayurveda, naturopathy, and traditional Indian values. He specifically highlighted a narrative suggesting that synthetic medicines have no solution for ailments such as blood pressure, diabetes, asthma, arthritis, liver disease, and kidney failure.
Ramdev asserted that Patanjali Ayurveda possesses substantial real-world and scientific evidence supporting the effectiveness of its medicines. He claimed success in treating various diseases, including type 1 diabetes, thyroid issues, high blood pressure, and obesity, through integrated and evidence-based treatments in yoga, Ayurveda, and naturopathy.
Despite the legal warnings, Ramdev respected the Supreme Court, the country’s law, and the Constitution. He defended Patanjali Ayurved’s stance, denying engagement in false propaganda and challenging authorities to impose severe penalties, even death if proven guilty.
Ramdev urged authorities to take decisive action against those involved in what he deemed “false propaganda” against yoga, naturopathy, Ayurveda, and India’s centuries-long medicinal traditions.
In a provocative statement, Ramdev accused certain individuals in modern medical science of possessing tamasic and rajasic qualities, referring to them as the ‘medical mafia.’ He suggested irritation among these individuals due to his previous criticism of allopathy.
Ramdev highlighted that Patanjali Ayurved has conducted over 500 research studies, incorporating real-world evidence, scientific findings, pre and post-clinical reports, clinical trials, and protocols. These studies, according to him, are publicly available online.
The Supreme Court’s directive places the onus on Patanjali Ayurved to cease misleading advertisements promptly. The court’s contemplation of substantial fines is a strong deterrent against deceptive health claims.
As the legal battle unfolds between Patanjali Ayurveda and the Indian Medical Association, it underscores the critical importance of responsible advertising, especially in the healthcare sector. The Supreme Court’s warning signals a commitment to preserving the integrity of medical information and safeguarding public health against deceptive marketing practices. This clash between traditional and modern medical perspectives raises questions about the balance between promoting indigenous practices and ensuring evidence-based healthcare for the public. The court’s decision will likely have far-reaching implications for the advertising landscape in India’s health and wellness sector.
Read More: India’s GDP Surpasses $4 Trillion: A Milestone or Mirage?
The ongoing crisis in Manipur has become a major concern for India, marked by ethnic…
A recent shootout in the Kabir Nagar area of Delhi has left one person dead…
An armed militant on Sunday killed seven individuals working on a tunnel project in the…
The recent violence in Bahraich has left the city grappling with a tense aftermath. In…
"The growth trajectory of MICE tourism in India reflects not just economic potential but also…
As Gahlaut himself often emphasizes, "Our mission is to create a balance where the fertilizer…